Bee Delightful – FDA Warning Letter, Dec 22, 2020

On December 22, 2020, the FDA issued a Warning Letter to Skyler R. Johnstone, owner of Bee Delightful, following an October 2020 review of their websites, www.beedelightful.com and www.facebook.com/BeeDelightfulUSA. The FDA determined that the company sells "Canna Bees Rescue Blend" products containing cannabidiol (CBD) with unapproved drug claims, including those related to mitigating, preventing, treating, diagnosing, or curing COVID-19.

The "Canna Bees Rescue Blend" products are deemed unapproved new drugs under sections 505(a) and 301(d) of the FD&C Act (21 U.S.C. 355(a) and 331(d)) because they are promoted with therapeutic claims (e.g., "Helps fight depression," "reduce the virus receptors by 73%"). They are also misbranded under section 502(f)(1) (21 U.S.C. 352(f)(1)) due to a lack of adequate directions for use, as the conditions they claim to treat are not amenable to self-diagnosis.

Furthermore, the products are adulterated under section 402(a)(2)(C)(i) (21 U.S.C. § 342